The goal of this Hybrid Type I effectiveness-implementation trial is to test Project nGage, an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among young Black men and women ages 18-49.
HIV Seropositivity
The goal of this Hybrid Type I effectiveness-implementation trial is to test Project nGage, an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among young Black men and women ages 18-49.
Hybrid Type I Effectiveness-Implementation Trial of Project nGage
-
University of Alabama at Birmingham 1917 Clinic, Birmingham, Alabama, United States, 35205
Birmingham AIDS Outreach, Birmingham, Alabama, United States, 35233
Thrive Alabama, Huntsville, Alabama, United States, 65801
Howard Brown Health, Chicago, Illinois, United States, 60613
Chicago Center for HIV Elimination, Chicago, Illinois, United States, 60637
Crown Family School of Social Work, Policy, and Practice at the University of Chicago, Chicago, Illinois, United States, 60637
Tulane University, New Orleans, Louisiana, United States, 70118
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 49 Years
ALL
Yes
University of Chicago,
Alida Bouris, PhD, PRINCIPAL_INVESTIGATOR, University of Chicago
David S Batey, PhD, PRINCIPAL_INVESTIGATOR, Tulane University
2027-12-31